The Myths and Misconceptions About STIs.
MEAN GIRLS, MOVIE (2004): You will get chlamydia, and die.
THE OFFICE, TV SHOW (2010): I know tonnes and tonnes of people who have herpes. I have it myself.
SEX EDUCATION, DRAMA SERIES (2020): Why is it like the walking dead in here? What is going on? Chlamydia. Everyone's got it!
Sexually transmitted infections are really common, but apart from a few pop culture references, we don't really talk about them. And it's left us exposed to growing infection rates, stigma, and a whole lot of misinformation.
SEX EDUCATION, DRAMA SERIES: One for a fiver, three for ten. You cannot catch chlamydia from the air. You have to have sexual contact with the carrier. Shh, they don't know that do they.
So if you're having sex or think you might one day, this is important stuff.
NIKKI BRANDON, SEXUAL HEALTH NURSE, SHINE SA: My name's Nikki Brandon, I am a sexual health nurse. In sexual health, we do things like STI screening, so screening for sexually transmitted infections, and we also do lots of work around contraceptions. Oh I love my job.
Nikki has been doing this for more than 30 years. So, we sat down with her to try and work through some of the big myths and misconceptions about STIs.
NIKKI BRANDON: Oh well probably the, the most obvious one is, 'oh it won't happen to me' but of course STIs don't discriminate. If you're sexually active, then it can certainly happen to you.
A sexually transmitted infection, or a STI, is an infection that can be passed from one person to another through sexual contact.
NIKKI BRANDON: Obviously they're spread through sexual intercourse, so through vaginal sex, oral sex, and anal sex, but they can also be spread through some close contact, so sometimes skin-to-skin contact is enough.
But what exactly are we spreading here? Well, first we have chlamydia, the most common STI in Australia.
NIKKI BRANDON: The main thing with chlamydia is it doesn't always have symptoms, or if it does have symptoms the symptoms just aren't enough to be recognised.
And here's a good spot to address misconception number two.
NIKKI BRANDON: People think if they don't have any symptoms, then they must be okay. A lot of the sexually transmitted infections don't actually have symptoms, so you can't rely on symptoms alone. If there are symptoms, it will be things like a genital discharge, pain passing urine, and sometimes it can cause pain in the belly.
Gonorrhoea is another big player and is quite similar to chlamydia in its symptoms. So again, you might get pain passing urine, discharge, irregular bleeding between periods or bleeding after sex. Next, we have syphilis.
NIKKI BRANDON: Syphilis has got a few stages of symptoms. So initially, there might be an initial sore, which usually doesn't hurt. And then what can happen with syphilis is you can have a rash that will go all over the body, but it can affect their hands and the soles of the feet as well. And that's quite unusual for a rash.
And one that you might have heard of is herpes.
NIKKI BRANDON: Herpes is certainly one of those infections that causes a lot of concern with people. It's a cold sore. So cold sores are very common. Genital herpes is basically just a cold sore down there. So, while it's annoying and it can be a bit painful, it's not there all the time. The virus will stay in your nervous system, but it doesn't mean you're always going to have the symptoms and it doesn't mean that you're always going to be infectious. But when the symptoms are on the skin surface, so when the blisters are out, that's when you're the most infectious and that's where you shouldn't have any activity. But when the symptoms have gone and the sores are all healed up, you're good to go.
But whether or not you have symptoms, STIs shouldn't go untreated. Chlamydia and gonorrhoea can actually progress to cause other conditions, which can lead to infertility or chronic pelvic pain. And with syphilis, it can end up damaging someone's vision, heart, lungs and bones, and can have devastating impacts on a pregnancy or the health of a baby.
NIKKI BRANDON: There certainly can be consequences of untreated STIs. That's why regular screening is so important because if you wait to rely on symptoms, the infection can actually be causing more damage than it should.
It's important to note that while we've mentioned some of the most common STIs, there are still others out there. In Australia, STI awareness really came into the spotlight in the 1980s during the HIV AIDS epidemic. At the time, some pretty full-on campaigns were shown on TV.
OLD HIV AIDS TV CAMPAIGN: One person dies from AIDS in Australia every second day and many more are becoming infected. AIDS is spread by sexual intercourse.
NIKKI BRANDON: Obviously HIV had put a lot of fear into people, so there was a lot fear, there was a lot terror actually. You probably remember the campaign with the Grim Reaper, it was, it was scary times, and, and you know everyone was so scared.
OLD HIV AIDS TV CAMPAIGN: AIDS can be stopped and you can help stop it. If you have sex, have just one safe partner or always use condoms, always.
That fear was effective when it came to getting the message across about safe sex, but these ads also created a lot of stigma around the queer community, particularly around gay men, because a HIV diagnosis was and still is most common among men who have sex with men, but some of that stigma still remains today.
NIKKI BRANDON: We're very much past that now. We've got excellent treatments for HIV. It's no longer the death sentence it was once perceived as being. We got treatments for people with HIV and we've got treatments to stop people developing HIV. We've absolutely come through that one.
But in the decades since the 1980s, the number of STIs recorded each year has been climbing. Over the last 20 years, chlamydia has roughly tripled in the number new cases diagnosed per year, bringing us to more than 100,000 cases last year. Gonorrhoea has increased massively over those same two decades, from 7,000 in 2004 to 44,000 in 2024, and syphilis, which we nearly got rid of in the early 2000s, has increased by almost ninefold to around 6,000 cases per year. It's fair to say STIs have become pretty common, to the point where one in six of us will get one at some stage.
SEX AND THE CITY, TV SHOW (2000): I always practice safe sex.
GLEE, TV SHOW (2014): Yeah, the doctor called me and said I tested positive. How is that possible? I don't know how. Well, do you wear condoms? No. Well, that would be how.
Well, a lot of us aren't actually being as safe as we could be, and that's what's leading to more infections.
NIKKI BRANDON: So we actually like to use the phrase safe first sex. Safe first sex will incorporate things like consent, using protection condoms is so important and I think that's getting a bit lost at the moment, but condoms are the one thing that does protect against sexually transmitted infections. Now people aren't so fearful of HIV. People aren't using condoms as much as they used to be and obviously along with those regular STI screenings.
While STI rates have gone up, testing has gone down. And a lot of that is because many of us don't actually know how testing works.
NIKKI BRANDON: You know, some people think, 'oh well, I had a test, you know, I've already had a test, so I should be fine.' It's not one and done, you need to have regular testing. Like going to the dentist, you know, it should be just a, a routine thing that people are talking about and caring about. For young people under the age of 30, it should be at least once a year. Ideally, to have a test before a new partner, that would be ideal, but yeah, certainly with changing sexual partners, or at least once a year. And another misconception is around screening. I think people think that you have to get undressed or you have show people bits and pieces. You don't.
STI testing is often as simple as a blood test, a urine test, or a swab. And in some cases, this can even be done at home. But sexual health clinics, your GP, Aboriginal health clinics or family planning centres are all good places to start. And each state has a sexual health service that you can call or email if you need more information. There's one more thing we have to do if we test positive for an STI.
THE OFFICE, TV SHOW: You need to contact every woman you've been with and notify them of your herpes infestation. It's the right thing to do.
SEX AND THE CITY, TV SHOW: She told me that I should contact all the people that I might've given it to, so they can all be treated.
HEARTBREAK HIGH, TV SHOW (2022): Just wanted to let you know that I have chlamydia, so you probably do as well.
NIKKI BRANDON: If people do test positive for an infection, you do have to tell your partners. So, telling people that you're having sex with is the most important way of actually eliminating all STIs.
Experts like Nikki say while we might find those conversations a bit embarrassing, we shouldn't feel any shame about having an STI. And proper treatment can put any misconceptions about how it impacts us long-term to bed.
NIKKI BRANDON: Oh no, no, you can absolutely have sex again. But this is why safe first sex is important. You know, use your protection, make sure all your activities are consensual, and like I say, regular testing. The important thing with all STIs is that if you're given treatment for an STI, you need to take the entire treatment, and that's it, it will go. You'll be, you'll be good to go again.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

ABC News
11 hours ago
- ABC News
Emergency department doctor says bad flu season not to blame for record ambulance ramping in WA
A senior emergency department physician says there is no basis to the WA government's claims a worse than average flu season is contributing to record high ambulance ramping hours. Figures from St John show ambulances spent more than 7,000 hours waiting outside WA's emergency departments in July, unable to transfer patients. It amounts to an average of 225 hours a day and surpasses the previous peak in August 2022 when ramping hours were close to 6,950. The government says an ageing population is one factor for the increase and has also pointed to higher influenza cases as a contributor. But Dr Peter Allely from the Australasian College for Emergency Medicine told ABC Radio Perth the problems were structural and much deeper than a bad flu season. "It's worse than it has been, but it's not unexpected that you'll get fluctuations in the number of flu patients from year to year," Dr Allely said. Australian Medical Association WA president Dr Kyle Hoath said innovative solutions were needed. "Is there an option for the government to open and run their own aged care facility, to try and have some control over that process?," he queried. "We know that every hospital bed in the private sector, that every new medi-hotel that's being built, are not full. There are beds there that could be used as hospital beds. We need to take advantage of that." WA Health Minister Meredith Hammatt said the latest figures were disappointing but was adamant the government was doing all it could. "We are attacking this from every angle," she said. "We've delivered over 900 beds to the hospital system since 2021. We've increased staff by 30 per cent and we're looking at innovative ways that we can deliver care closer to home, where people live." Ms Hammatt said she expected a number of initiatives, already in place, would have an impact. "We're looking at all the ways that we can make a difference throughout a whole patients journey through the system, from when they first think that they may need an ambulance, right through to the point of discharge," she said. "And particularly for our older West Australians, making sure they've got appropriate care that they can access. "That's why we've done things like stood up the WA virtual emergency department, that's why we've made sure we've got a central point of coordination for ambulances through the state. "That's why we're going to deliver older adult health hubs for older West Australians and we have an election commitment to ensure that there are low interest loans available to do more aged care in WA. "And of course, we want the federal government to do more to ensure that there's aged care available for older West Australians." Opposition Leader Basil Zempilas called on Premier Roger Cook to make ambulance ramping his top priority. "They have waved the white flag," he said. "Nine years to fix it. In nine years, it's gone from 1,000 hours of ramping to a record of 7,000 hours of ambulance ramping."

ABC News
11 hours ago
- ABC News
New study finds safety protection on quad bikes is driving down farm deaths
New research has found rollover and crush protection on quad bikes is leading to a reduction in farm deaths, particularly in Victoria. A preliminary report published in the Australian and New Zealand Journal of Public Health examined whether mandatory rollover protection introduced in 2020–21 had improved safety. The lead author, honorary associate professor Tony Lower from AgHealth Australia, said the figures showed that fewer people were dying. "Of course, we'd like to see it at zero but, all being said, it is headed in the right direction, which is a really fantastic effort," Dr Lower said. The research shows that 161 people died in work-related quad bike deaths in Australia between 2001 and 2024, averaging seven fatal crashes a year. Nearly all deaths happened on farms and 65 per cent of them were the result of rollovers. The data shows that work-related quad bike deaths peaked in 2016–17, but dropped by 2024 after the new safety measures were introduced. "Rule changes like this can have significant outcomes on people's lives," Dr Lower said. "It's addressed a long-term issue with the stability of quad bikes and the potential if they do roll over to prevent crush and asphyxiation injuries." The figures revealed a significant reduction in work-related quad bike deaths and rollovers in Victoria in recent years. Deaths in Queensland also went down, but the numbers rose slightly in New South Wales. "In Victoria, there's been a larger requirement for enforcing the fitting of those operator protection devices," Dr Lower said. "They've also worked with farmers to ensure that things like helmets and the vehicles are in good maintenance. Felicity Richards, chairperson of Farmsafe Australia, said it was heartening to see a reduction "even if that is only small nationally". "We're really hopeful that quad bikes will ultimately follow that trajectory of tractors … with the introduction of rollover protection, there's been incredibly significant improvements in outcomes," Ms Richards said. Ms Richards said it would be interesting to see if further research could confirm that regulatory enforcement was making a difference. "Our focus has been on encouraging people to create a culture where they are doing things like always having (operator protection devices) on the bike, always assessing the terrain and the training of the person using it, and always wearing the helmet," she said. Dr Lower acknowledged that more research was needed into quad bike deaths since the safety changes, particularly around enforcement. "One of our recommendations is to actually look exactly at what Victoria's done, why it's worked, and look at that in more in depth," he said.

News.com.au
11 hours ago
- News.com.au
Scott Power: ASX health stocks stumble but rotation into sector ‘picks up steam'
ASX heath sector falls 0.65 % in past five days but returns 9% in July in a strong comeback 'Mostly pretty good' June quarterly reporting season comes to end Clarity Pharmaceuticals completes $203 million capital raise to institutional investors Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his take on the ASX healthcare sector for the week and his 'Powerplay' stock pick. After 5% and 5.4% gains over the past two weeks and being up for most of the week the ASX Health Care Index (ASX:XHJ) fell 0.65% in the past five days after heavy falls across broader markets on Friday as US tariff concerns again played on investor sentiment. The benchmark S&P/ASX 200 (ASX:XJO) finished the week fairly flat, up 0.01%. However, in some good news the healthcare sector has had a strong start to FY26 up 9% in July after a disappointing FY25 in which it finished down 4%. "The rotation into healthcare seems to be picking up steam and our sense is that this is likely to continue into FY26," Morgans' senior healthcare analyst Scott Power said. "The small end of the sector is looking particularly attractive." ImpediMed doubles unit sales as Mach7 welcomes new CEO As the June quarter reporting season wraps up, Power described it as 'mostly pretty good' for the sector with a few noteworthy ones released this week. ImpediMed (ASX:IPD) sold a record 44 of its lymphodema detection devices called Sozo in its target US market during the June quarter, double the March quarter. Total contract value was also a record with $6.3 million for the quarter. "It was a solid quarter and I think they've really started to turn the corner in terms of the US install base," Power said. Morgans maintains a speculative buy on ImpediMed with a 12-month 15 cent target price. Health imaging stock Mach7 Technologies (ASX:M7T) reported its Q4 FY25 result with Power saying while there were no major surprises and most information flagged in a recent trading update, outlook from its new CEO Terri Thomas was positive. Mach7 reiterated FY25 guidance of revenue between $33m-$34m and CARR of ~$30m-$31m. Power this week caught up with Thomas, who took over on July 1 and was previously head of former ASX-listed breast imaging company Volpara Technologies, which was taken over by South Korean firm Lunit last year. "In the first 30 days Terri has been there she's made some changes and with her guiding hand I think in the next 12 months we're going to see Mach7 kick some big goals," Power said. "The company is moving towards profitability as well." Morgans has an add rating on Mach7 and 12-month target price of $1.37. Provider of oral appliance treatments for sleep-related breathing disorders and obstructive sleep apnea (OSA) Somnomed (ASX:SOM) delivered top-line growth ahead of expectations, with strong performances in key markets North America and Europe. Growth was driven by both new and returning customers, as well as successful price increases across its product range. With previous manufacturing delays now largely resolved, SomnoMed is planning to expand production capacity by more than 25% in FY26. In a note to client analyst Iain Wilkie said the increased manufacturing capacity combined with more efficient turnaround should leave Somnomed in a strong place to handle expected continued growth over the short-term. "FY25 has been a strong year for SOM and the market has responded positively to it, up ~50% over the past 12 months and up 250% since May 2024 following the overhaul of the business with a new management team, repayment of its debt facilities, and addressing manufacturing inefficiencies," Wilkie wrote. Consensus target price for Somnomed is 80 cents. Micro-X supply agreement marks turning point Micro-X (ASX:MX1) rose ~40% on Wednesday after news it had tapped into a network of 700 hospitals with a three-year supply agreement through a major US healthcare provider, the first of its kind for the company. Micro-X secured the contract after a highly competitive tender process and a successful in-hospital trail of its Rover Plus mobile radiology system. The company is in discussions with a second major procurement group for a similar supply agreement. It's good news for the company, which has undertaken a strategic review of its operations and is now focusing on medical imaging for its cold cathode X-ray technology, halting further work on its Argus bomb detection device after the commercial launch didn't attract sufficient customer interest. "The agreement they've signed is good validation that their strategy on focusing on the medical imaging side of the business is paying off," Power said. Micro-X is also developing a head CT scanner and full body lightweight portable CT scanner. A security project – an airport baggage scanner self-check-in – is being funded by the US Department of Homeland Security. "They are getting paid to develop that system but the core focus is back on medical imaging," Power said. "Clearly it is now paying off and they're talking about potential other agreements coming through. Morgans has a speculative buy rating on Micro-X and 12-month target price of 17 cents. Clarity completes mammoth $203 milllion capital raise Radiopharmaceutical group Clarity Pharmaceuticals (ASX:CU6) completed a large $203m institutional placement, struck at a 15% premium to the company's 15-day average price, to fund their clinical program. "The capital raise was a pretty big achievement for them," Power said. Executive chairman Dr Alan Taylor told Stockhead the 'fast, well executed and sizeable' placement was to a small group of local institutional investors "close to the company'. "I have never done a deal that fast," Taylor said. "A week ago, I would have said we were not doing a capital raising, but there was a lot of interest from a very concentrated group ." Power's Powerplay: 'Solid set of numbers' for Aroa New Zealand soft tissue repair company Aroa Biosurgery (ASX:ARX) reported its third consecutive quarter of positive net cash flow since listing on the ASX in July 2020 and reaffirmed its FY26 revenue guidance. Operating on the New Zealand financial year, cash flow from operations for the June quarter was NZ$1.7m, with cash receipts of $22.5m. Net cash outflows from investing activities for the quarter were NZ$900,000, primarily reflecting routine capital expenditure. Net cash flow was NZ$500,000 with total cash on hand increasing by NZ$200,000, after adjusting for the impact of movements in exchange rates. The company ended the quarter with a cash balance of NZ$22.2m. "Importantly, the company reaffirmed full-year FY26 total revenue guidance of NZ$92–100m representing growth of 20% at the top end which is where we sit and are happy to sit there," Power said. "They've reported a solid set of numbers." Normalised EBITDA for FY26 of NZ$5–8m represents growth of 19–90% on FY25. "Aroa has really turned the corner and is now producing sustainable profits going forward," Power said. Morgans maintains a speculative buy and 12-month target price of 77 cents on Aroa. The views, information, or opinions expressed in the interview in this article are solely those of the interviewee and do not represent the views of Stockhead. Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this article. At Stockhead, we tell it like it is. While Aroa Bisurgery is a Stockhead advertiser, the company did not sponsor this article.